Clinical Trials Logo

West Nile Viral Infection clinical trials

View clinical trials related to West Nile Viral Infection.

Filter by:
  • None
  • Page 1

NCT ID: NCT02337868 Completed - Clinical trials for West Nile Viral Infection

Phase 1 Trial of Inactivated West Nile Virus Vaccine

Start date: March 31, 2015
Phase: Phase 1
Study type: Interventional

This trial will be a randomized, placebo controlled, double-blind (within dosing group), dose escalation phase 1 trial, evaluating dosages of 1 mcg and 4 mcg of HydroVax-001 WNV vaccine given intramuscularly on Day 1 and Day 29 in up to 50 healthy adults > /=18 and < 50 years of age. The primary objective is to assess the safety, reactogenicity, and tolerability of the HydroVax-001 WNV vaccine administered intramuscularly in a two-dose series on Days 1 and 29 at a dose of 1 mcg or a dose of 4 mcg.